home / stock / clls / clls articles

CLLS Articles, Cellectis S.A. - From 04/08/24

Stock Information
Company Name: Cellectis S.A.
Stock Symbol: CLLS
Market: NASDAQ
Website: cellectis.com
Menu
CLLS CLLS Quote CLLS Short CLLS News CLLS Articles CLLS Message Board
Get CLLS Alerts

News, Short Squeeze, Breakout and More Instantly...
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting | Benzinga

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneerin...
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca | Benzinga

Execution of binding subsequent investment agreement regarding contemplated additional equity investment of $140M by AstraZeneca, previously anno...

Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual Meeting | Benzinga

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) --  Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneeri...

Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...
Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 39.7% to $0.1143 in pre-market trading after falling 17% on Wednesday. LumiraDX recently anno...

Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023 | Benzinga

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering...

Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged | Benzinga

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision. The Dow traded up 0.40% to 33,185.41&...
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers Cellectis S.A. (NASDAQ: CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with As...

Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today? | Benzinga

Cellectis SA (NASDAQ: CLLS) shares are trading higher after the company announced a research agreement with AstraZeneca Plc&nbs...

Nasdaq Surges Over 100 Points Ahead Of Fed Decision; WeWork Shares Plunge | Benzinga

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday. The Dow traded up 0.55% to 3...
Previous 10 Next 10